109 related articles for article (PubMed ID: 24756862)
1. Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma.
Campos B; Gal Z; Baader A; Schneider T; Sliwinski C; Gassel K; Bageritz J; Grabe N; von Deimling A; Beckhove P; Mogler C; Goidts V; Unterberg A; Eckstein V; Herold-Mende C
J Pathol; 2014 Sep; 234(1):23-33. PubMed ID: 24756862
[TBL] [Abstract][Full Text] [Related]
2. Autocrine factors sustain glioblastoma stem cell self-renewal.
Li G; Chen Z; Hu YD; Wei H; Li D; Ji H; Wang DL
Oncol Rep; 2009 Feb; 21(2):419-24. PubMed ID: 19148517
[TBL] [Abstract][Full Text] [Related]
3. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
[TBL] [Abstract][Full Text] [Related]
6. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy.
Xie XP; Laks DR; Sun D; Ganbold M; Wang Z; Pedraza AM; Bale T; Tabar V; Brennan C; Zhou X; Parada LF
Dev Cell; 2022 Jan; 57(1):32-46.e8. PubMed ID: 35016005
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
[TBL] [Abstract][Full Text] [Related]
8. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
[TBL] [Abstract][Full Text] [Related]
9. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
10. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
Fukaya R; Ohta S; Yamaguchi M; Fujii H; Kawakami Y; Kawase T; Toda M
Cancer Lett; 2010 May; 291(2):150-7. PubMed ID: 19913993
[TBL] [Abstract][Full Text] [Related]
11. The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network.
Gürsel DB; Berry N; Boockvar JA
Neurosurgery; 2012 Feb; 70(2):N19-21. PubMed ID: 22251985
[No Abstract] [Full Text] [Related]
12. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells.
Chirasani SR; Sternjak A; Wend P; Momma S; Campos B; Herrmann IM; Graf D; Mitsiadis T; Herold-Mende C; Besser D; Synowitz M; Kettenmann H; Glass R
Brain; 2010 Jul; 133(Pt 7):1961-72. PubMed ID: 20513660
[TBL] [Abstract][Full Text] [Related]
13. The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
De Bacco F; Casanova E; Medico E; Pellegatta S; Orzan F; Albano R; Luraghi P; Reato G; D'Ambrosio A; Porrati P; Patanè M; Maderna E; Pollo B; Comoglio PM; Finocchiaro G; Boccaccio C
Cancer Res; 2012 Sep; 72(17):4537-50. PubMed ID: 22738909
[TBL] [Abstract][Full Text] [Related]
14. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
16. G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells.
Kaur G; Kim J; Kaur R; Tan I; Bloch O; Sun MZ; Safaee M; Oh MC; Sughrue M; Phillips J; Parsa AT
J Clin Neurosci; 2013 Jul; 20(7):1014-8. PubMed ID: 23693024
[TBL] [Abstract][Full Text] [Related]
17. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility.
Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T
J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694
[TBL] [Abstract][Full Text] [Related]
18. Identification of cancer stem cells in dog glioblastoma.
Stoica G; Lungu G; Martini-Stoica H; Waghela S; Levine J; Smith R
Vet Pathol; 2009 May; 46(3):391-406. PubMed ID: 19176492
[TBL] [Abstract][Full Text] [Related]
19. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells.
Bischof J; Westhoff MA; Wagner JE; Halatsch ME; Trentmann S; Knippschild U; Wirtz CR; Burster T
Tumour Biol; 2017 Mar; 39(3):1010428317692227. PubMed ID: 28347245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
